About the Authors
- Hisashi Urushihara
-
* E-mail: urushihara.hisashi.2s@kyoto-u.ac.jp
Affiliation Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan
- Masanori Taketsuna
-
Affiliation Asia-Pacific Statistical Sciences, Eli Lilly Japan K.K., Kobe, Hyogo, Japan
- Ying Liu
-
Affiliation Global Patient Safety Japan, Eli Lilly Japan K.K., Kobe, Hyogo, Japan
- Eisei Oda
-
Affiliation Medical TOUKEI Corporation, Shinjuku-ku, Tokyo, Japan
- Masaki Nakamura
-
Affiliation Business Development Department, Medical Data Vision Co., Ltd., Chiyoda-ku, Tokyo, Japan
- Shinichi Nishiuma
-
Affiliation Global Patient Safety Japan, Eli Lilly Japan K.K., Kobe, Hyogo, Japan
- Rei Maeda
-
Affiliation Global Patient Safety Japan, Eli Lilly Japan K.K., Kobe, Hyogo, Japan
Competing Interests
HU has served as a consultant to Eli Lilly Japan and received a research grant from Pfizer Health Research Foundation. MT, YL, SN, and RM are full-time employees of Eli Lilly Japan. EO is the President of Medical TOUKEI Corporation. MN is a full-time employee of Medical Data Vision Co., Ltd. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: HU MT YL EO SN RM. Analyzed the data: EO MN. Wrote the paper: HU. Acquisition of data: MN. Interpreted the data: HU MT YL EO MN SN RM. Critical revision of the manuscript for important intellectual content: HU MT YL SN RM.